Seller Financing

Monterey County Family & Geriatric Practice

WebHelper_Admin / September 8, 2026

An established primary care practice is available for acquisition in California. The practice has built a stable, Medicare-weighted patient panel, strong patient relationships, and an established foundation for value-based care. The practice offers an established operating platform and experienced support team. The owner is transitioning out of the practice. KEY INVESTMENT HIGHLIGHTS Approximately 550 attributed senior lives, providing an established foundation for a value-based-care strategy • Consistent historical financial performance • Strong historical revenue and seller earnings • Medicare-weighted payor mix with an established patient base • Strong Medicare Annual Wellness Visit participation and patient engagement • Approximately 1,500 active patients and 5,000 annual encounters • Bilingual physician and support team serving a diverse patient population WHY THIS PRACTICE For a physician seeking ownership, this practice offers an established platform with patient relationships, referral sources, established value-based-care infrastructure, electronic medical records, outsourced revenue-cycle support, and an experienced bilingual support team. The current owner has created an efficient operating model that provides a buyer with an established platform from day one. For a regional primary care or multispecialty group looking to expand in California, the practice offers an established patient base, Medicare concentration, value-based-care infrastructure, and additional capacity for growth. The established senior patient base provides a platform that would otherwise take significant time and resources to develop organically. The bilingual team and adjacent expansion space provide a clear path to increased capacity. FINANCIAL SUMMARY Historical financial performance and detailed financial information are available to qualified buyers following execution of an NDA. TRANSACTION Transaction terms and detailed financial information are available to qualified buyers following execution of an NDA. NEXT STEP A signed NDA grants access to the full Confidential Information Memorandum, which includes detailed financial breakdowns, payor mix analysis, complete service-line revenue, lease documentation, and other operational detail. Serious inquiries only. In Association with broker, Scott Reid of ParaSell, Inc. (California Lic #02101543)

Turnkey Orange County Endocrinology Practice — Owner-Light, Retiring

strategicmedicalbrokers / August 1, 2026

A rare opportunity to acquire an established, profitable endocrinology practice in Orange County, California, operating continuously from the same location since 2009. The defining feature for a buyer is its independence from the founder: the physician-owner personally provides only about 10–12% of annual patient encounters, while three long-tenured Nurse Practitioners — all with the practice since 2018 — independently manage the majority of routine endocrine care under physician supervision, supported by an Office Manager who has run daily administration since 2012. The single biggest risk in buying a physician practice — that the practice is the physician — has largely been engineered out. The practice serves a strong, referral-driven patient base of roughly 8,000 patient encounters per year across office visits and telemedicine, with a standing new-patient wait list of two months in a market with a well-documented shortage of endocrinologists. Demand consistently exceeds current provider capacity. The financials are clean and durable: no business debt, no litigation, no liens. The payor base is favorably weighted toward managed care — Medicare, managed Medi-Cal, and numerous HMOs, IPAs, and MSOs — with most contracts paying approximately 110–120% of Medicare rates, and participation in an Accountable Care Organization adds recurring performance-based incentive payments on top of office-visit collections. Gross collections were approximately $1.39 million in 2025, producing Seller’s Discretionary Earnings of about $449,000 (a ~32% margin); SDE has averaged roughly $426,000 over the past five years. The clinical and administrative team is experienced, multilingual (English, Spanish, and Vietnamese), and exceptionally stable, and is expected to remain through and after a transition. Operations run on a long-established electronic health record with minimal anticipated capital expenditure. This is a turnkey acquisition for a board-certified endocrinologist ready to own an independent practice with an established referral network and no start-up risk, or for an endocrinology or multi-specialty group seeking a low-risk Orange County foothold with unrealized growth capacity. The owner is retiring after more than 17 years and will support a mutually agreed transition. Offered at $890,000 — $790,000 cash at close plus $100,000 in seller financing available to a qualified physician buyer (approximately 2.0x SDE). The facility is leased, not owned. A signed NDA and buyer qualification are required for the full information package. Practice identity is withheld to protect confidentiality. Presented by Strategic Medical Brokers in association with ParaSell, Inc.

Florida Primary Care Practice – 1,558 Medicare Advantage Lives

strategicmedicalbrokers / July 11, 2026

THIS IS NOT AN EARNINGS ACQUISITION. IT IS A PANEL ACQUISITION. A 30+ year solo-physician family medicine practice in North Central Florida is available. Its principal asset is not its income statement. It is 1,558 Medicare Advantage lives – a concentrated senior panel, managed for chronic disease, in one of the most Medicare-dense counties in the United States. At the $1,800,000 offering price, that panel transfers at approximately $1,155 per Medicare Advantage life. For context, ECG Management Consultants – writing for the American Health Law Association – reports that non-health system buyers \”might pay up to $12,000 per Medicare Advantage life\” for primary care practices, precisely because of the value of managing that population under risk-based contracts. The gap between those two numbers is the opportunity here. WHY THE GAP EXISTS Plainly: a retiring solo physician never monetized the panel he built. – The office is open 32 scheduled hours per week and closes at 3:00 p.m. (noon Fridays). – It holds NO capitated contracts. – It joined an Accountable Care Organization (ACO) in 2024 and has taken NO shared savings. – It has NO website, no online scheduling, no SEO, no advertising, no business cards. – 2025 revenue was $702,869 with $115,493 of discretionary earnings. Every one of those is a lever the seller could not pull and a buyer can. Asked to name the biggest bottleneck in the business, the owner answered in three words: \”Probably my time.\” WHAT YOU ACQUIRE – 1,558 Medicare Advantage patients. More than half of all patients are 65+; pediatric patients are rare. – A genuinely comorbid panel: diabetes, hypertension, hyperlipidemia, thyroid disorders, renal failure, CHF, atrial fibrillation, CAD, PAD, fatty liver disease, metabolic syndrome – the exact clinical profile that drives risk-adjusted revenue in a value-based model. – ACO participation already in place, with none of its economics harvested. – Care-management muscle already in the building: the medical assistants already make the chronic care management calls. The hardest thing to buy in a value-based rollout – staff who will actually work a panel between visits – is already habit here. – Six long-tenured employees, two with 25+ years of service. Ownership anticipates the team would remain post-close. – A clean compliance record: no litigation, liens, OIG integrity agreements, program exclusions, HIPAA breaches, or outstanding taxes. – ~10 new patients per month, arriving on reputation alone. ~4.5-star average online. – Real estate available separately at $675,000 (approx. $218/SF), or lease at $4,650/month NNN. THE MARKET Florida is one of only seven states where more than 60% of Medicare beneficiaries are enrolled in Medicare Advantage. The county is among Florida\’s oldest and fastest-growing: per the U.S. Census Bureau, 29.7% of its 442,660 residents are 65 or older – against 18.0% nationally – and the population has grown 17.8% since 2020. THE CANDID RISK The owner is retiring, will not remain post-close, does not plan to practice in the area, and will sign a standard non-compete. In a solo practice that is the central risk in any acquisition, and it is why the panel is priced where it is. What offsets it: chronic-care patients who do not casually relocate their care (some have been with the practice 30 years), a staff expected to stay, a flexible transition, and a $300,000 seller-carryback note that keeps the seller invested in a successful handoff. TERMS $1,800,000 offering price. $1,500,000 cash at close; $300,000 seller carryback to a qualified physician buyer, secured by practice assets and personal guaranty. $25,000 minimum earnest money. Accounts receivable excluded. Real estate offered separately. Presented to qualified, NDA-executed parties only. Contact the broker for the Confidential Information Memorandum. Presented by Strategic Medical Brokers in association with ParaSell, Inc.

Turnkey Family Practice, Omaha NE Metro | $2.8M Rev

strategicmedicalbrokers / July 10, 2026

Rare opportunity to acquire a well-established, full-service family medicine practice serving the Bellevue and greater Omaha, NE metro for 40+ years. This is a turnkey platform with a loyal, multi-generational patient base — not a startup and not a fixer-upper. The incoming physician steps into a full schedule and an experienced team from day one. KEY HIGHLIGHTS • ~$2.8M gross collections (2025) with strong Seller\’s Discretionary Earnings of ~$880K. • Runs largely WITHOUT the owner: the physician-owner accounts for only ~12-16% of collections. Four experienced PA-Cs and a tenured management team drive daily production and operations — neutralizing the #1 risk of buying a doctor-owned practice. • ~19,000 annual encounters, ~7,000 active patients, 36,000+ records, and 15-20 new patients/week — almost entirely by word of mouth, with minimal marketing spend. • Premium payor profile: ~70% commercial insurance, low Medicaid exposure. • Differentiated, high-margin CASH-PAY service lines: anti-aging & regenerative medicine, hormone replacement (including pellet therapy), peptide therapy, genetic testing, and a pharmaceutical-grade supplement line. • Vertically integrated: on-site full lab and X-ray reduce referral leakage and capture ancillary revenue. • Clean operation: no debt, no litigation, no compliance issues, no liens. • 8,600 sq ft single-level facility, 20-25 exam rooms — capacity for additional providers and extended hours. • Fully independent — no MSO, ACO, CIN, or hospital affiliation. Full clinical and operational autonomy. • Award-winning local reputation; longest-running family practice in its county. IDEAL BUYER An employed physician ready for independence, a regional family-medicine group expanding into the Midwest, or a wellness/anti-aging platform acquirer seeking an established cash-pay engine inside a profitable primary care base. TRANSITION Planned, orderly succession. The owner will support an extended, compensated transition to protect continuity of care, and the experienced staff is expected to remain. OFFERED AT $1,600,000 — $1,440,000 cash at close plus $160,000 seller financing available to a qualified physician buyer. Competitive physician-practice financing and SBA 7(a) options available.  Qualified buyers must sign an NDA and complete a buyer profile. Contact us for the full Confidential Information Memorandum. All figures are Seller-provided and subject to buyer verification in due diligence. Presented by Strategic Medical Brokers in association with ParaSell, Inc.

West Phoenix Primary Care: 3,022 Patients, Seller Financing

strategicmedicalbrokers / June 25, 2026

Established internal medicine and primary care practice in West Phoenix, Arizona, offered for acquisition. The practice serves a loyal, well-insured panel of 3,022 active patients – including 1,457 senior (age 65+) lives – from a single, modern clinic running on the eClinicalWorks EMR platform. This is a rare opportunity to acquire a turnkey primary care platform with a high-quality payer mix. Approximately 61% of patients carry commercial insurance, with another 23% on Medicare or Medicare Advantage and only about 6% on Medicaid (AHCCCS). The book is diversified across 124 distinct payers, with no single carrier exceeding roughly 18% of the panel – limiting reimbursement-concentration risk. Engagement is strong: about 90% of patients are active and roughly 72% have been seen within the past 12 months. The patient base skews toward attractive, recurring primary-care demand. Median patient age is 61, the panel is balanced by gender, and a large 50-64 cohort is steadily aging into Medicare – supporting chronic-care management, annual wellness visits, and value-based care opportunities for years to come. The business was recently created by consolidating three legacy clinic locations into the single West Phoenix office now offered. Trailing gross revenues were approximately $1.65M (2023), $2.10M (2024), and $1.49M (2025), a three-year average near $1.74M. The 2025 figure reflects the consolidation/transition year rather than patient attrition – the active panel and payer mix remain intact. Notably, the practice has been operated remotely by out-of-state ownership, leaving clear upside for a hands-on owner-operator or local platform to drive organic growth. The offering is structured as an asset sale at $550,000, with $175,000 in seller financing available to qualified buyers (10-year amortization, 10% interest, balloon due in 48 months) – reducing upfront capital and reflecting the seller\’s confidence in a smooth transition. Furniture, fixtures, medical equipment, and supplies are included; accounts receivable are excluded. The clinical real estate is held by a related entity and available to lease. Qualified, interested parties must execute a confidentiality agreement to receive the full Confidential Information Memorandum and supporting due-diligence materials. All inquiries are handled exclusively through the broker.

High-Growth SW Florida Pediatric Practice – $3M Rev, 200+ Waitlist

strategicmedicalbrokers / June 13, 2026

A profitable, fast-growing outpatient pediatric practice in one of the fastest-growing cities in the United States is available for acquisition. Founded in 2022, the practice has scaled rapidly to roughly $3.0 million in annual revenue, with seller\’s discretionary earnings of about $933,000 (approximately a 31% margin). Revenue has nearly doubled every year since opening. The practice serves more than 8,000 patients across Southwest Florida and maintains a waitlist of over 200 families, clear evidence that demand exceeds current capacity. New patients arrive through a steady newborn referral pipeline from area hospitals and midwives, reinforced by strong word-of-mouth among local families. Care is delivered by six providers (a physician plus advanced practice providers) and supported by a 19-person team, including an experienced general manager who runs day-to-day operations. This management depth lowers key-person risk and supports a smooth ownership transition. The practice runs an efficient two-location model that separates well-child and sick visits across dedicated facilities, improving patient flow, infection control, and capacity, with room to add a provider. Services span newborn and well-child care, sick visits, immunizations, physicals, and management of common pediatric conditions, plus specialized in-office procedures. This is an ideal opportunity for an employed physician seeking independence and ownership, or for a group practice expanding its Southwest Florida footprint. Offered at $1,450,000, including $1,300,000 cash at close plus a $150,000 seller note to a qualified buyer. Accounts receivable are excluded. The seller is exiting for lifestyle and family reasons and will provide transition support and a customary non-compete. A signed confidentiality agreement is required to receive the full Confidential Information Memorandum. Presented by Strategic Medical Brokers in association with ParaSell, Inc.

Profitable Allergy & Immunology Practice – Growth Upside, Central AZ

strategicmedicalbrokers / June 9, 2026

Established, profitable allergy, asthma & immunology practice in Central Arizona (Pinal County), on the I-10 corridor between the Phoenix and Tucson metros. For more than 30 years this referral-driven practice has served a loyal patient base, yet it operates only about one and a half days per week, leaving substantial unused capacity in a fast-growing market. Highlights: – Approximately 900 active patients and 370+ patients on ongoing immunotherapy (allergy shots). – Documented gross revenues holding near $800,000 annually, with estimated seller\’s discretionary earnings of roughly 40% of revenue. – Comprehensive services: aeroallergen, food, patch and venom testing; pulmonary function testing; customized immunotherapy; and biologic therapies for asthma and chronic urticaria. – Diversified payor mix weighted toward Medicare, commercial, and TRICARE. – Approximately 2,300 sq. ft. office configured for, and capable of supporting, two providers. The opportunity: the local market has no full-time, board-certified allergist, and patients currently travel to Phoenix and Tucson for specialty care. A buyer who expands clinic hours toward full-time operation can capture demand that already exists. For an allergist or practice owner already operating in Maricopa, Pinal, or Pima County, this is a natural satellite (bolt-on) acquisition: share back-office, billing, immunotherapy compounding, and purchasing across an existing location, then deploy a provider to add clinic days. The current owners have run this exact satellite model for three decades, so the playbook is proven. The financial snapshot is based on documented gross revenues; SDE reflects an estimated ~60% overhead, and a buyer able to share costs with an existing practice may operate at a higher margin. Offered at $495,000: $445,000 cash at close plus $50,000 in seller financing to a qualified physician buyer (secured by practice assets and personal guaranty). Accounts receivable excluded. $25,000 earnest money to open escrow. A seller transition is available by mutual agreement. This is a confidential listing. The business name and identifying details are withheld to protect patients, staff, and referral relationships. Qualified, financially capable buyers will be asked to sign a confidentiality agreement to receive the full Confidential Information Memorandum. Inquiries are handled exclusively through Strategic Medical Brokers.

Profitable Value-Based Primary Care Platform | ~40% Capitated

strategicmedicalbrokers / June 7, 2026

Rare opportunity to acquire a profitable, founder-led primary care platform in one of the most Medicare Advantage-dense markets in the country (South Broward County, Florida). Unlike the fee-for-service practices that dominate the acquisition market, this practice has already made the transition to value-based care: roughly 40% of revenue is capitated – recurring monthly per-member payments tied to panel size, supplemented by quality and shared-savings incentives. The practice serves approximately 7,000 active patients, including about 1,200 Medicare Advantage and 540 traditional Medicare lives (a ~1,740-life Medicare panel), and participates in accountable care organizations (ACOs) and clinically integrated networks with active HEDIS quality reporting. That infrastructure – established payor relationships, quality-reporting discipline, and a recurring risk-based revenue base – is exactly what strategic and financial buyers pursuing value-based care are competing to acquire. FINANCIAL HIGHLIGHTS – 2025 gross revenue: $3,317,705 (a five-year high) – 2025 discretionary earnings (SDE): $957,304 (28.9% margin) – Five-year average owner earnings above $1,000,000 – Asking price: $2,100,000 The earnings profile is uncommon among independent primary care practices and is directly attributable to the recurring, capitated payor mix that cushions the practice from fee-for-service volume swings. Top-line revenue has grown three years running. Founder continuity de-risks the transition. The board-certified founding physician intends to remain with the practice after closing and continue treating patients – preserving patient, staff, payor, and referral relationships through the transition, the single biggest risk in any primary care acquisition. The clinical team includes two physicians, two physician assistants, and a nurse practitioner, supported by roughly 25 experienced administrative and clinical staff, many with 10-15+ years of tenure. An offer has been extended to an additional physician assistant. The practice occupies a modern facility of roughly 5,217 sq. ft. with 13 exam rooms and capacity for at least one additional provider today – a built-in runway for panel and revenue growth with no major capital expense. Growth has come almost entirely through referrals and word-of-mouth (4.8-star average rating, 500+ reviews), leaving digital marketing, online scheduling, deeper value-based contracting, Medicare Advantage panel expansion, and added ancillary services as clear, low-cost levers for a new owner. Seller financing is available to a qualified physician buyer ($300,000 seller-carryback note; $1,800,000 cash at close), signaling genuine confidence in continuity and post-close performance – an alignment of incentives that materially de-risks the transaction. Serious, qualified buyers must execute a confidentiality/non-disclosure agreement to receive the full Confidential Information Memorandum, detailed financials, and a management discussion. Accounts receivable are excluded from the sale. In Association with ParaSell, Inc. | A Licensed Florida Broker

Mohs & Derm Practice | Coastal CT

strategicmedicalbrokers / June 3, 2026

A 20-year-old, fully independent Mohs surgery and medical dermatology practice in coastal southeastern Connecticut is available for acquisition. This is a direct-to-physician opportunity — not structured for private equity, MSOs, or financial acquirers. The ideal buyer is a fellowship-trained Mohs surgeon or board-certified dermatologist ready to own and operate an established, fully operational practice in one of coastal New England’s most desirable communities. A board-certified dermatologist who is not personally Mohs-fellowship-trained may also acquire the practice, provided they employ a fellowship-trained Mohs surgeon to perform the Mohs caseload. KEY METRICS: • $400,000 seller financing for qualified physician buyers • 16,820 annual encounters | 11,150 established patients | 1,000–1,200 Mohs cases/yr • Avg base collections/encounter: $398 | Payer mix: 62% Medicare, 34% commercial — no Medicaid • Google rating: 4.7 / 5.0 | Founded 2006 2025 REVENUE NOTE: 2025 included a non-recurring skin-substitute (placental allograft) revenue stream the practice is discontinuing in 2026 due to Medicare reimbursement changes. The valuation deliberately normalizes this out; buyers should model from normalized SDE, not 2025 reported figures. Full detail provided under NDA. WHAT YOU’RE ACQUIRING: Three experienced providers — a fourth joining mid-2026 — all expected to remain post-sale. PA-Cs generate 55–60% of base net collections through medical dermatology, biopsies, and procedures, feeding Mohs cases directly to the physician-owner. This built-in referral engine reduces key-person risk and supports a full schedule from day one. Full procedural breadth: Mohs micrographic surgery, CLIA-certified in-office histopathology lab, excisions, biopsies, cryotherapy, allergy patch testing, SRT, ALA photodynamic therapy, and cosmetic Botox. The incoming physician steps into a complete clinical infrastructure — no build phase, no rebranding, no stabilization period. FINANCING: Conventional medical practice financing at competitive rates (currently sub-6%, 15-year amortization) for qualified physician buyers; SBA 7(a) also available; $400,000 seller financing. Exclusively represented by Strategic Medical Brokers | 888-970-1210 | smt.webhelper.in/

Request a Valuation

Book a Discovery Meeting